Single-center, single dose, open-label study in healthy male and female volunteers to further characterize the transfer potential of Testosterone Gel 1.62% formulation.

Single-center, single dose, open-label study in 12 healthy male and 12 healthy female volunteers to further characterize the transfer potential of Testosterone Gel 1.62% formulation.

Inclusion Criteria

• BMI between 20-35 kg/m^2 inclusive.

Exclusion Criteria

• Males: history, current or suspected prostate or breast cancer.
• Females: pregnant or lactating.